Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Evidence-based toxicology: a comprehensive framework for causation.

Philip S Guzelian1, Michael S Victoroff, N Christine Halmes

  • 1University of Colorado Health Science Center, Box B-146, 4200 East 9th Avenue, BRB 723, Denver, CO 80262, USA. phil.guzelian@uchsc.edu

Human & Experimental Toxicology
|June 17, 2005
PubMed
Summary

This study introduces evidence-based toxicology (EBT) to differentiate known risks from mere possibilities in chemical safety assessments. EBT provides a structured framework for toxicologists to improve the reliability of causation and risk evaluations.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Natural Product N-Palmitoyl-l-leucine Selectively Inhibits Late Assembly of Human Spliceosomes.

The Journal of biological chemistry·2015
Same author

Tumors that mimic asbestos-related mesothelioma: time to consider a genetics-based tumor registry?

Frontiers in genetics·2014
Same author

Impact of electronic health records on malpractice claims in a sample of physician offices in Colorado: a retrospective cohort study.

Journal of general internal medicine·2012
Same author

Silver(I)-promoted conversion of thioamides to amidines: divergent synthesis of a key series of vancomycin aglycon residue 4 amidines that clarify binding behavior to model ligands.

Journal of the American Chemical Society·2012
Same author

Redesign of glycopeptide antibiotics: back to the future.

ACS chemical biology·2012
Same author

Total synthesis of [Ψ[C(═S)NH]Tpg4]vancomycin aglycon, [Ψ[C(═NH)NH]Tpg4]vancomycin aglycon, and related key compounds: reengineering vancomycin for dual D-Ala-D-Ala and D-Ala-D-Lac binding.

Journal of the American Chemical Society·2011

Area of Science:

  • Toxicology
  • Risk Assessment
  • Causation Analysis

Background:

  • Current toxicology practices exhibit deficiencies in evaluating causation and risk.
  • The term 'risk' is ambiguously used for both known events and mere possibilities.
  • Authority-based opinions have historically influenced toxicological decisions over rigorous evidence.

Purpose of the Study:

  • To address deficiencies in toxicological risk and causation evaluation.
  • To formulate an evidence-based solution for distinguishing known risks from nomological possibilities.
  • To establish a formal method for evidence-based toxicology (EBT).

Main Methods:

  • Developed a three-stage, 12-step framework for EBT, derived from evidence-based medicine (EBM) principles.
  • Adapted EBM's systematic review approach for assembling and critiquing scientific literature.

Related Experiment Videos

  • Incorporated structured evaluation of study design strength and execution quality for causation analysis.

    • Main Results:

    • The EBT framework provides a systematic approach to collecting and evaluating data and knowledge.
    • It enables rigorous assessment of literature to determine fulfilled causation criteria.
    • The method distinguishes between established risks (epistemic possibilities) and uncertain nomological possibilities.

    Conclusions:

    • EBT offers a formalized method for differentiating settled toxicological knowledge from mere possibilities.
    • This approach enhances the objectivity and reliability of causation and risk evaluations in toxicology.
    • Adoption of EBT is crucial for advancing toxicology as a rigorous scientific discipline.